BOOSTRIX
INJ SUS ISP 20X0,5ML+20J
| SÚKL code | 0120104 |
|---|---|
| Name of the product | BOOSTRIX |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | BOOSTRIX |
| Supplement | INJ SUS ISP 20X0,5ML+20J |
| Strenght | |
| Pharmaceutical form | Suspension for injection in pre-filled syringe |
| Package | 20X0,5ML+20J |
| Route | Intramuscular use |
| Language of the pack | Czech |
| Wrap type | Pre-filled syringe |
| Legal status | na lékařský předpis |
| Active substance |
DIPHTHERIA TOXOID (DIPHTHERIAE ANATOXINUM) TETANUS TOXOID (TETANI ANATOXINUM) PERTUSSIS TOXOID (PERTUSSIS ANATOXINUM) PERTUSSIS FILAMENTOUS HAEMAGGLUTININ (PERTUSSIS HAEMAGGLUTININUM FILAMENTOSUM) PERTACTIN (PERTACTINUM) |
| ATC group | J07AJ52 |
| ATC group name | PERTUSE, PURIFIKOVANÝ ANTIGEN, KOMBINACE S TOXOIDY |
Marketing authorisation information
| Registration Number | 59/ 495/07-C |
|---|---|
| Type of MA | A mutual recognition procedure (MRP, DCP), where CZ is Concerned member state |
| MA status | B - medicinal product after change, may be placed on the market for the period of 6 months (Placed on the market till) and used until expiration, not later than till the end of validity of the marketing authorisation (Valid till) |
| Placed on the market till | 30. 09. 2022 |
| MA Holder | GlaxoSmithKline, s.r.o. |
| MA Holder country | ČESKÁ REPUBLIKA |
| Actual MA holder | GlaxoSmithKline, s.r.o. |
| Actual MA holder country | ČESKÁ REPUBLIKA |
cz